Female adolescents prescribed teratogens receive inadequate contraception provision (counseling, referral, and/or prescribing of contraception), which could increase the risk for negative pregnancy outcomes. This according to a study of 1,694 females aged 14 to 25 years and 4,172 clinic visits in which a known teratogen was prescribed. Researchers found:
• Contraceptive provision was documented in 28.6% of the visits.
• The most commonly prescribed teratogens were topiramate, methotrexate, diazepam, isotretinoin, and enalapril.
• Subspecialties prescribing teratogens most frequently were neurology, hematology-oncology, and dermatology.
• Whites vs nonwhites and older vs younger girls were more likely to receive contraceptive provision.
• The presence of a federal risk mitigation system for the teratogen also increased the likelihood of contraceptive provision.
Citation: Stancil SL, Miller M, Briggs H, Lynch D, Goggin K, Kearns G. Contraceptive provision to adolescent females prescribed teratogenic medications. [Published online ahead of print December 16, 2015]. Pediatrics. doi: 10.1542/peds.2015-1454.
This Week's Must Reads
Must Reads in Contraception
Bleeding and Spotting with the LNG 13.5 mg IUS, Contraception; ePub 2019 Mar 1; Shimoni, et al
Contraception and Chronic Opioid Prescriptions, Contraception; ePub 2019 Feb 11; Ray-Griffith, et al
Hormonal Contraception & Coexisting Medical Conditions, Obstet Gynecol; ePub 2019 Feb; Allen, et al
Contraceptive Switching & Discontinuation, Am J Obstet Gynecol; ePub 2018 Dec 18; Simmons, et al
Efficacy of a Levonorgestrel 52-mg IU System, Obstet Gynecol; ePub 2018 Dec 4; Teal, et al